Our Science • Our science stories

UCB Stories

Can AI reinvent drug design?

Posted by Luis Castro, Discovery Science 18-Nov-2019

Read more
Like
Life in the lab: Students sample life as a UCB scientist

Posted by Karen Borrer, BII Communications 08-Aug-2019

Read more
Like
Could anti-tau immunotherapy treat neurodegenerative diseases?

Posted by Jean-Philippe Courade, Neurosciences TA Biology 02-May-2019

Read more
Like
Getting personal: improving the lives of people with skin diseases

Posted by Matladi Ndlovu, Patient Value Unit - Immunology 24-Apr-2019

Read more
Like
It’s not because it’s ‘Rare’ that we care

Posted by Chris Clark, Patient Value Unit - Neurology 25-Feb-2019

Read more
Like
New partnership with King’s College London enhances academic collaboration

Posted by Laurent Schots, Global Communications & Company Reputation 20-Feb-2019

Read more
Like
UCB’s commitment to epilepsy

Posted by Allyson Funk, US Communications and Public Relations 20-Nov-2018

Read more
Like
New approach accelerates drug discovery

Posted by Rafal Kaminski, Patient Value Unit - New Medicines 05-Sep-2018

Read more
Like
Celebrating 10 years of innovating together

Posted by Katharina Klapper, Public-Private Partnerships Europe 04-Jul-2018

Read more
Like
Partnership with Science 37: helping UCB to improve patient experience

Posted by Tero Laulajainen, UCB Biosciences, Global Clinical Science and Operations 07-May-2018

Read more
Like

Our Company